These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6642671)

  • 21. Isolation of human monoclonal antibodies binding to B fragment of diphtheria toxin.
    Gupta KC; Agha R; Santos E; Brodeur BR
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):25-31. PubMed ID: 1576320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative in vitro and in vivo assessment of toxin neutralization by anti-tetanus toxin monoclonal antibodies.
    Yousefi M; Khosravi-Eghbal R; Reza Mahmoudi A; Jeddi-Tehrani M; Rabbani H; Shokri F
    Hum Vaccin Immunother; 2014; 10(2):344-51. PubMed ID: 24126015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterization of a novel human monoclonal antibody that neutralizes tetanus toxin.
    Simpson LL; Lake P; Kozaki S
    J Pharmacol Exp Ther; 1990 Jul; 254(1):98-103. PubMed ID: 1694896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and construction of immune phage antibody library against Tetanus neurotoxin: Production of single chain antibody fragments.
    Sadreddini S; Seifi-Najmi M; Ghasemi B; Kafil HS; Alinejad V; Sadreddini S; Younesi V; Jadidi-Niaragh F; Yousefi M
    Hum Antibodies; 2015 Dec; 23(3-4):73-9. PubMed ID: 27472865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production and characterization of monoclonal antibodies against Clostridium perfringens type A enterotoxin.
    Wnek AP; Strouse RJ; McClane BA
    Infect Immun; 1985 Nov; 50(2):442-8. PubMed ID: 2865210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of Fc fragment of monoclonal antibodies to tetanus toxin neutralization.
    Ghotloo S; Amiri MM; Khoshnoodi J; Abbasi E; Jeddi-Tehrani M; Golsaz-Shirazi F; Shokri F
    Neurotox Res; 2020 Mar; 37(3):578-586. PubMed ID: 31721050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C.
    Mazzantini RP; Miyaji EN; Dias WO; Sakauchi D; Nascimento AL; Raw I; Winter N; Gicquel B; Rappuoli R; Leite LC
    Vaccine; 2004 Jan; 22(5-6):740-6. PubMed ID: 14741167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human monoclonal antibodies with a protective activity against tetanus toxin.
    Trabaud MA; Lery L; Desgranges C
    APMIS; 1989 Aug; 97(8):671-6. PubMed ID: 2475149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy with human monoclonal antibodies. Fragment A specificity of polyclonal and monoclonal antibodies is crucial for full protection against tetanus toxin.
    Lang AB; Cryz SJ; Schürch U; Ganss MT; Bruderer U
    J Immunol; 1993 Jul; 151(1):466-72. PubMed ID: 8326138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single human monoclonal antibody that confers total protection from tetanus.
    Arunachalam B; Ghosh S; Talwar GP; Raghupathy R
    Hybridoma; 1992 Apr; 11(2):165-79. PubMed ID: 1376715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
    Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
    Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diversity of the antibody response to tetanus toxoid: comparison of hybridoma library to phage display library.
    Sorouri M; Fitzsimmons SP; Aydanian AG; Bennett S; Shapiro MA
    PLoS One; 2014; 9(9):e106699. PubMed ID: 25268771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Requirement of at least two distinct monoclonal antibodies for efficient neutralization of tetanus toxin in vivo.
    Mizuguchi J; Yoshida T; Sato Y; Nagaoka F; Kondo S; Matuhasi T
    Naturwissenschaften; 1982 Dec; 69(12):597-8. PubMed ID: 6186924
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative analysis of tetanus antitoxin titers of sera from immunized mice and guinea pigs determined by toxin neutralization test and enzyme-linked immunosorbent assay.
    Gupta RK; Siber GR
    Biologicals; 1994 Sep; 22(3):215-9. PubMed ID: 7811454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response in mice following immunization with DNA encoding fragment C of tetanus toxin.
    Anderson R; Gao XM; Papakonstantinopoulou A; Roberts M; Dougan G
    Infect Immun; 1996 Aug; 64(8):3168-73. PubMed ID: 8757849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the immune response to papain digestion products of tetanus toxin.
    Helting TB; Nau HH
    Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):59-63. PubMed ID: 6711309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of neutralizing human monoclonal antibody directed to tetanus toxin in CHO cell.
    Chin J; Sohn Y; Lee SH; Park YI; Choi MJ
    Biologicals; 2003 Mar; 31(1):45-53. PubMed ID: 12623059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic peptide antigens of tetanus toxin.
    Fischer PM; Howden ME
    Mol Immunol; 1994 Oct; 31(15):1141-8. PubMed ID: 7935502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A solid-phase enzyme immunoassay for the detection of tetanus toxin using human and murine monoclonal antibodies.
    Kiessig ST; Hentschel C; Jahn S; Mehl M; Starke R; Porstmann T
    J Basic Microbiol; 1991; 31(2):135-40. PubMed ID: 1880715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.